International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Open Access | Fully Refereed | Peer Reviewed

ISSN: 2319-7064


Downloads: 5 | Weekly Hits: ⮙2 | Monthly Hits: ⮙5

Informative Article | Biology | United States of America | Volume 10 Issue 10, October 2021


COVID-19 Vaccines: A Path to Normalcy at HBCUs

Lawrence O. Flowers


Abstract: The COVID-19 pandemic has affected virtually every aspect of human life. One of the hardest - hit sectors of American life has been the educational sector. Since SARS - CoV - 2 is an enormously successful pathogen, the decision to transition from in - person learning to a remote learning structure was justified and necessary. Historically Black Colleges and Universities (HBCUs) were particularly economically vulnerable academic institutions during the pandemic compared to non - HBCUs, given lower enrollments and funding disparities that have existed for over a century. According to many credible reports, the messenger ribonucleic acid (mRNA) vaccines from Moderna and Pfizer - BioNTech are safe and efficacious. mRNA vaccines are a departure from conventional vaccine technology that relied on attenuated or inactivated microbial pathogens. Instead, mRNA vaccines are nucleotide sequences packaged in a lipid - containing particle designed to stimulate human production of the SARS - CoV - 2 spike protein to activate human immune mechanisms to deal with future pathogenic challenges. The emergence of viable mRNA vaccines offers hope to reopen HBCUs; however, reopening must be coordinated and compliant with state and federal safety guidelines.


Keywords: COVID-19, mRNA vaccine, HBCU, mitigation strategies


Edition: Volume 10 Issue 10, October 2021,


Pages: 33 - 35


How to Cite this Article?

Lawrence O. Flowers, "COVID-19 Vaccines: A Path to Normalcy at HBCUs", International Journal of Science and Research (IJSR), https://www.ijsr.net/get_abstract.php?paper_id=SR21930185219, Volume 10 Issue 10, October 2021, 33 - 35

How to Share this Article?

Enter Your Email Address


Top